The deoxyribonucleic (DNA) content was measured by microspectrophotometry in 100 specimens from 60 patients with ulcerative colitis, including six patients in whom the colitis was associated with carcinoma. Some 23 of 30 (77%) specimens of dysplastic tissue showed aneuploidy or polyploidy, whereas 50 of 53 (94%) specimens of non-dysplastic tissue showed diploidy. The difference was statistically significant (p<0.001). Polyploidy was often observed in non-dysplastic mucosa from patients who had carcinoma or dysplasia. In the non-dysplastic patients all samples of inflamed tissue showed diploidy. Some 10% of samples without inflammation, however, also showed polyploidy. A good correlation was found between the frequency of polyploid cells and the grade ofdysplasia. Microspectrophotometric measurement of DNA content proved useful in the assessment and diagnosis of dysplasia in ulcerative colitis and could be considered for screening high risk patients.
The risk of colorectal carcinoma in patients with longstanding ulcerative colitis has been well established. At one time prophylactic proctocolectomy was recommended for those with total colonic involvement and more than 10 years' history of colitis. In 1967 Morson and Pang suggested that the presence of epithelial dysplasia in the rectal biopsy specimen might help to identify high risk patients.' A prospective study has been started at St Mark's Hospital, London, to determine whether high risk patients can be safely followed up by regular colonoscopic biopsy to detect dysplasia as an alternative to prophylactic surgery. 2 Dysplasia in ulcerative colitis is defined as an unequivocal neoplastic change in the colonic epithelium.' A dysplastic lesion is macroscopically detectable as a polypoid or plaque-like lesion, but it also develops in flat mucosa. 4 Dysplasia used to be graded as mild, moderate, and severe, as in colonic adenoma. But in recent years the Dysplasia Morphology Study Group has recommended a new classification of dysplasia as negative, indefinite, low grade, and high grade. 3 The group has formulated guidelines for the clinical management of high risk patients. In this study dysplasia was graded according to this classification.
Recent studies on dysplasia have shown the following unresolved problems5'-:
(1) The classification of dysplasia is subject to inter-and intraobserver variation; (2) Interpretation is particularly difficult where there is acute inflammation.
Solving these problems has prompted a search for more objective methods of determining dysplasia such as the analysis of DNA content.8
In Japan, the frequency of carcinoma in patients with ulcerative colitis has tended to increase in recent years and about 60 cases were reported up to 1989. There are, however, only a few reports of dysplasia and no reports of DNA abnormality in ulcerative colitis.
In 1987 a prospective microspectrophotometric DNA study of patients with longstanding ulcerative colitis was begun at this hospital. We present the results of this study together with the results from a retrospective study before 1986 and compare the outcome with the experience from western countries.
Methods

PATIENTS
One hundred colonic specimens from 60 patients with ulcerative colitis were studied (Table I) . There were 36 men and 24 women with a mean age of 42 1 years and a mean disease history of 9-6 years. Thirty six samples from 10 The DNA content was analysed in 7 p.m sections initially and then, where aneuploid cells were detected, in smears. All but overlapping or fragmentary nuclei in the sections were measured at random. To determine the DNA ploidy patterns in sections, properly cut mitotic cells were selectively measured because they were considered to contain almost whole amounts of nuclear DNA. " More than 50 or 100 nuclei were measured at random in the sections or in the smears respectively. Twenty lymphocytes were measured in each specimen to define 2c DNA content as a control.
DEFINITION AND STATISTICS
The DNA peak was defined as diploid when it deviated less than 20% from the standard lymphocyte peak. It was classified as aneuploid when the major peak of the DNA histogram (Fig 1(d) negativefor dysplasia.
DURATION OF DISEASE
The relation between DNA ploidy and the duration of disease in 56 patients with ulcerative colitis (excluding proctitis) is shown in Figure 2 . Although no statistically significant difference is seen, all patients with aneuploidy and five of seven with polyploidy were found to have had colitis for more than seven years.
FREQUENCY OF POLYPLOIDY
The ratio of polyploid cells to the total number of cells counted was calculated for 99 specimens (except an adenoma) (Fig 3) . The mean ratios for carcinoma, high grade, and low grade dysplasia were 10-3, 7 0, and 3-3% respectively (Table II) . Twenty two of 30 (73%) samples of dysplastic tissues contained more than 2% polyploid cells. Only 3 of 53 (6%) non-dysplastic specimens, however, had a ratio greater than 2%. The difference is statistically significant (p<0-00 1). We noted that sensitivity to detect malignancy increased when aneuploidy and polyploidy were included. In this study, 77% of 30 dysplastic specimens, including carcinoma and dysplasia, were DNA aneuploid or polyploid, whereas 6% of 53 non-dysplastic samples were DNA polyploid (statistically significant). This indicates that microspectrophotometric DNA aneuploidy or polyploidy is highly suggestive of malignancy, as has been shown by some authors using flow cytometry. 13 (Table II) .
The distribution of the percentage of polyploid cells in the total number of cells measured is interesting. The mean values of carcinoma, high grade, and low grade dysplasia were 10-3, 7-0, and 3-3% respectively, and 73% of 30 dysplastic samples had the over 6c polyploidy frequency of more than 2% as compared with only 6% of 53 non-dysplastic specimens (statistically significant, p<0 001). Therefore, this 2% ratio for polyploidy frequency was considered to be a marker for the presence of dysplasia. A statistical study using the non-parametric Wilcoxon rank sum test was undertaken to determine the significant differences between various groups. As shown in Table III , the more separate from each other in the spectrum of dysplasia the groups were, the more significant the difference between the groups. These results indicate that the percentage of polyploid cells could be useful for the diagnosis of dysplasia.
Among non-dysplastic specimens, 10% of the specimens in the inactive phase were polyploid while all those in the active phase were diploid. Hammarberg et al also reported that much larger numbers of specimens were aneuploid in the inactive phase than in the active phase (Table  IV) .8 Further studies may be necessary before the clinical implications ofthese findings become clear. Since all the non-dysplastic active samples were diploid, however, and as the active phase did not disturb the DNA measurement in the diagnosis of dysplasia, we believe that microspectrophotometric analysis may be helpful in discriminating true dysplasia from inflammatory reactive change. '8 The presence of aneuploidy in specimens that were indefinite for dysplasia and polyploidy in specimens indefinite for dysplasia, background mucosa, and inactive mucosa needs further explanation for clinical application. Although the presence of polyploidy suggests premalignant change or at least change towards malignancy on a DNA level, it is not clear yet whether this change is irreversible and will definitely lead to a clinically malignant condition in the future.
As normal cells do not usually show polyploidy we consider that the colon which contains polyploid cells is abnormal, and patients are put on a close surveillance programme to see the long term outcome as far as developing overt dysplasia is concerned. In particular, patients with specimens indefinite for displasia that show aneuploidy or polyploidy are being kept under close observation.
In conclusion, our current results clearly show the usefulness of microspectrophotometric DNA analysis as a supplementary tool in the diagnosis of dysplasia in patients with longstanding ulcerative colitis. Furthermore, this technique may be able to detect much earlier precancerous change on a DNA level, even in non-dysplastic normal looking mucosa.9 " Longterm studies are required, however, to confirm the clinical usefulness of this new method. 
